Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02232308 · ClinicalTrials.gov registry record · Phase 1
Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
A Phase 1 study of Gastroparesis, sponsored by Adil Bharucha.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT02232308 is a Phase 1 study of Gastroparesis that has completed, run by Adil Bharucha. The registered enrollment target is 24 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02232308, a Phase 1 study of Gastroparesis, has completed, sponsored by Adil Bharucha.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
To assess if oral nizatidine or lisinopril alone and in combination will increase heme oxygenase 1 (HO-1) protein concentration and activity compared to placebo in healthy subjects.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Lisinopril
- DRUG Nizatidine
Study Locations (2)
Minnesota
- Mayo Clinic in Rochester - Rochester
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-07 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02232308
The ClinicalTrials.gov registry entry for NCT02232308 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (92% lower). The listed sponsor is Adil Bharucha, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02232308 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02232308 about?
NCT02232308 is a clinical study titled "Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects". To assess if oral nizatidine or lisinopril alone and in combination will increase heme oxygenase 1 (HO-1) protein concentration and activity compared to placebo in healthy subjects.
What is the current status of trial NCT02232308?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2014-07. Estimated completion is 2014-09.
What conditions does trial NCT02232308 study?
This clinical trial studies the following conditions: Gastroparesis.
What interventions are being tested in trial NCT02232308?
The interventions under investigation include: Placebo (DRUG), Lisinopril (DRUG), Nizatidine (DRUG).
Who is sponsoring clinical trial NCT02232308?
This trial is sponsored by Adil Bharucha, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02232308 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TENS in Scleroderma
RECRUITING · Phase 1
-
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
COMPLETED · Phase 1
-
Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers
COMPLETED · Phase 1
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Study of Gastric Motility in Eosinophilic Gastritis
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.